Cancer Capital (CNCL) 10-K 28 Mar 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 17, 2014
Document And Entity Information	'	'
Entity Registrant Name	'Cancer Capital Corp.	'
Entity Central Index Key	'0001130889	'
Document Type	'10-K	'
Document Period End Date	31-Dec-13	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Accelerated Filer	'
Entity Public Float	'	$0
Entity Common Stock, Shares Outstanding	'	6,150,000
Document Fiscal Period Focus	'FY	'
Document Fiscal Year Focus	'2013	'

Balance_Sheets

Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current Assets	'	'
Cash	$3,387	$419
Total Current Assets	3,387	419
Total Assets	3,387	419
Current Liabilities	'	'
Accounts Payable - related party	19,700	20,275
Accounts Payable	'	881
Notes payable - related party	53,025	28,250
Notes payable	60,225	52,725
Accrued interest - related party	2,530	'
Accrued Interest	4,509	'
Total Current Liabilities	139,989	102,131
Total Liabilities	139,989	102,131
Stockholders' Deficit	'	'
Common Stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding	6,150	6,150
Additional Paid in Capital	47,050	47,050
Deficit accumulated during the development stage	-189,803	-154,912
Total Stockholders' Deficit	-136,603	-101,712
Total Liabilities and Stockholders' Deficit	$3,387	$419

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Statement of Financial Position [Abstract]	'	'
Common stock; par value	$0.00	$0.00
Common Stock; shares authorized	20,000,000	20,000,000
Common stock; shares issued	6,150,000	6,150,000
Common stock; shares outstanding	6,150,000	6,150,000

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended		201 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Income Statement [Abstract]	'	'	'
Revenues	'	'	'
Operating Expenses	'	'	'
General and administrative	27,852	29,467	182,764
Total expenses	27,852	29,467	182,764
Loss from operations before other expense	-27,852	-29,467	-182,764
Other income (expense), non-operating	'	'	'
Interest expense – related party	-2,530	'	-2,530
Interest expense	-4,509	'	-4,509
Total other income (expense)	-7,039	'	-7,039
Loss from operations before income taxes	-34,891	-29,467	-189,803
Income taxes	'	'	'
Net loss	($34,891)	($29,467)	($189,803)
Basic and diluted net loss per share	($0.01)	$0	'
Weighted Average shares outstanding	6,150,000	6,150,000	'

Statements_of_Stockholders_Def

Statements of Stockholders' Deficit (USD $)	Common Stock	Additional Paid-In Capital	Accumulated Deficit During the Development Stage
Beginning balance, Amount at Apr. 10, 1997	$0	$0	$0
Beginning balance, Shares at Apr. 10, 1997	0	'	'
Common stock, issued at inception for cash at $.001 per share, Shares	1,000,000	'	'
Common stock, issued at inception for cash at $.001 per share, Amount	1,000	'	'
Common stock, issued at inception for services at $.001 per share, Shares	200,000	'	'
Common stock, issued at inception for services at $.001 per share, Amount	200	'	'
Common stock issued for cash at $.01 per share, Shares	3,500,000	'	'
Common stock issued for cash at $.01 per share, Amount	3,500	31,500	'
Net Income (loss)	'	'	-22,400
Ending balance, Amount at Dec. 31, 1997	4,700	31,500	-22,400
Ending balance, Shares at Dec. 31, 1997	4,700,000	'	'
Net Income (loss)	'	'	-9,900
Ending balance, Amount at Dec. 31, 1998	4,700	31,500	-32,300
Ending balance, Shares at Dec. 31, 1998	4,700,000	'	'
Net Income (loss)	'	'	-1,300
Ending balance, Amount at Dec. 31, 1999	4,700	31,500	-33,600
Beginning balance, Shares at Dec. 31, 1999	4,700,000	'	'
Common stock issued for services at $.01 per share, Shares	200,000	'	'
Common stock issued for services at $.01 per share, Amount	200	1,800	'
Common stock issued for services at $.02 per share, Shares	250,000	'	'
Common stock issued for services at $.02 per share, Amount	250	4,750	'
Net Income (loss)	'	'	-7,600
Ending balance, Amount at Dec. 31, 2000	5,150	38,050	-41,200
Ending balance, Shares at Dec. 31, 2000	5,150,000	'	'
Net Income (loss)	'	'	'
Ending balance, Amount at Dec. 31, 2001	5,150	38,050	-41,200
Ending balance, Shares at Dec. 31, 2001	5,150,000	'	'
Net Income (loss)	'	'	-5,139
Ending balance, Amount at Dec. 31, 2002	5,150	38,050	-46,339
Beginning balance, Shares at Dec. 31, 2002	5,150,000	'	'
Common stock issued for services at $.01 per share, Shares	1,000,000	'	'
Common stock issued for services at $.01 per share, Amount	1,000	9,000	'
Net Income (loss)	'	'	-11,245
Ending balance, Amount at Dec. 31, 2003	6,150	47,050	-57,584
Ending balance, Shares at Dec. 31, 2003	6,150,000	'	'
Net Income (loss)	'	'	-2,070
Ending balance, Amount at Dec. 31, 2004	6,150	47,050	-59,654
Ending balance, Shares at Dec. 31, 2004	6,150,000	'	'
Net Income (loss)	'	'	-7,016
Ending balance, Amount at Dec. 31, 2005	6,150	47,050	-66,670
Beginning balance, Shares at Dec. 31, 2005	6,150,000	'	'
Net Income (loss)	'	'	-7,207
Ending balance, Amount at Dec. 31, 2006	6,150	47,050	-73,877
Ending balance, Shares at Dec. 31, 2006	6,150,000	'	'
Net Income (loss)	'	'	-10,082
Ending balance, Amount at Dec. 31, 2007	6,150	47,050	-83,959
Ending balance, Shares at Dec. 31, 2007	6,150,000	'	'
Net Income (loss)	'	'	-5,052
Ending balance, Amount at Dec. 31, 2008	6,150	47,050	-89,011
Ending balance, Shares at Dec. 31, 2008	6,150,000	'	'
Net Income (loss)	'	'	-4,809
Ending balance, Amount at Dec. 31, 2009	6,150	47,050	-93,820
Ending balance, Shares at Dec. 31, 2009	6,150,000	'	'
Net Income (loss)	'	'	-5,723
Ending balance, Amount at Dec. 31, 2010	6,150	47,050	-99,543
Ending balance, Shares at Dec. 31, 2010	6,150,000	'	'
Net Income (loss)	'	'	-25,902
Ending balance, Amount at Dec. 31, 2011	6,150	47,050	-125,445
Ending balance, Shares at Dec. 31, 2011	6,150,000	'	'
Net Income (loss)	'	'	-29,467
Ending balance, Amount at Dec. 31, 2012	6,150	47,050	-154,912
Ending balance, Shares at Dec. 31, 2012	6,150,000	'	'
Net Income (loss)	'	'	-34,891
Ending balance, Amount at Dec. 31, 2013	$6,150	$47,050	($189,803)
Ending balance, Shares at Dec. 31, 2013	6,150,000	'	'

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended		201 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'	'
Net Loss	($34,891)	($29,467)	($189,803)
Adjustments to reconcile Net Income to net cash provided by operations:	'	'	'
Common stock issued for services rendered	'	'	17,200
Expenses paid by related party	19,700	20,275	68,225
Changes in assets and liabilities	'	'	'
Increase (decrease) in accounts payable and accrued expenses	-880	-550	'
Accrued interest	7,039	'	7,039
Net cash provided by Operating Activities	-9,032	258	-44,614
CASH FLOWS FROM INVESTING ACTIVITIES	'	'	'
Net cash provided by investing activities	'	'	'
CASH FLOWS FROM FINANCING ACTIVITIES	'	'	'
Cash advances- related party	4,500	'	4,500
Proceeds from advances and notes payable	7,500	10,000	60,225
Common stock issued for cash	'	'	36,000
Net cash provided by Financing Activities	12,000	10,000	100,725
Net Increase (Decrease) in Cash	2,968	258	3,387
Cash and cash equivalents at beginning of period	419	161	'
Cash and cash equivalents at end of period	3,387	419	3,387
Supplemental Disclosures	'	'	'
Cash paid for interest	'	'	'
Cash paid for income taxes	'	'	'
Non-cash Investing and Financing Activities	'	'	'
Converted accounts payable and advances into loans	20,275	28,250	48,525
Stock issued for services	'	'	$17,200

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	A. Organization & Summary of Significant Accounting Policies
	Cancer Capital Corp. (the Company), was incorporated April 11, 1997 under the laws of the State of Nevada. The Company was originally formed for the purpose of developing an alternative medical waste treatment system. However, the Company in December 1997 minimized this purpose and since that time its efforts have been directed more to raising capital, development of the Company’s business plan, SEC filings and other limited operations.
	B. Recognition of Revenue
	The Company has adopted FASB ASC 605 which provides guidance on the recognition, presentation and disclosure of revenue in financial statements filed with the SEC. FASB ASC 605 outlines the basic criteria that must be met to recognize revenue and provides guidance for disclosure related to revenue recognition policies. In general, the Company recognizes revenue related to monthly services provided when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) the fee is fixed or determinable and (iv) collect ability is reasonably assured.
	C. Loss Per Share
	The computation of earnings per share of common stock is based on the weighted average number of shares outstanding at the date of the financial statements. There are not potentially dilutive common stock equivalents.
		For the Years Ended
		December 31,
		2013			2012
	Net Loss	$	(34,891	)	$	(29,467	)
	Weighted Average Number of Shares Outstanding		6,150,000			6,150,000
	Basic Loss per Common Share	$	(0.01	)	$	(0.00	)
	D. Cash and Cash Equivalents
	The Company considers all highly liquid investments with maturities of three months or less to be cash equivalents.
	E. Use of estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	F. Concentrations of Risk
	As of December 31, 2013, two lenders represent in excess of 95% of the Company’s Accounts Payable and Notes Payable for the fiscal years ended December 31, 2013 and December 31, 2012.
	G. Reclassification
	Certain amounts in prior-year financial statements have been reclassified for comparative purposes to conform to the presentation in the current year financial statements.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	NOTE 2 - INCOME TAXES
	The Financial Accounting Standards Board (FASB) has issued FASB ASC 740-10 (Prior authoritative literature: Financial Interpretation No. 48, "Accounting for Uncertainty in Income Taxes - An Interpretation of FASB Statement No. 109 (FIN 48). FASB ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements in accordance with prior literature FASB Statement No. 109, Accounting for Income Taxes.  This standard requires a company to determine whether it is more likely than not that a tax position will be sustained upon examination based upon the technical merits of the position. If the more-likely-than- not threshold is met, a company must measure the tax position to determine the amount to recognize in the financial statements.  As a result of the implementation of this standard, the Company performed a review of its material tax positions in accordance with recognition and measurement standards established by FASB ASC 740-10.
	Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	The Company currently has no issues creating timing differences that would mandate deferred tax expense. Net operating losses would create possible tax assets in future years. Due to the uncertainty of the utilization of net operating loss carry forwards, a valuation allowance has been made to the extent of any tax benefit that net operating losses may generate. A provision for income taxes has not been made due to net operating loss carry-forwards of $ 189,803 and $ 154,912 as of December 31, 2013 and December 31, 2012, respectively, which may be offset against future taxable income through 2031. No tax benefit has been reported in the financial statements.
	Deferred tax assets and the valuation account are as follows:
		For the Years Ended
		December 31,
		2013			2012
	Deferred tax asset:
	Net operating loss carryforward	$	64,533		$	52,670
	Valuation allowance		(64,533	)		(52,670	)
		$	0		$	0
	The components of income tax expense are as follows:
		For the Years Ended
		December 31,
		2013			2012
	Current Federal tax	$	0		$	0
	Current State tax		0			0
	Change in NOL benefit		11,863			10,080
	Change in valuation allowance		(11,863	)		(10,080	)
		$	0		$	0
	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
		For the Years Ended
		December 31,
		2013			2012
	Beginning Balance	$	0		$	0
	Additions based on tax positions related to current year		0			0
	Additions for tax positions of prior years		0			0
	Reductions for tax positions of prior years		0			0
	Reductions in benefit due to income tax expense		0			0
	Ending Balance	$	0		$	0
	The Company did not have any tax positions for which it is reasonably possible that the total amount of unrecognized tax benefits will significantly increase or decrease within the next 12 months.
	The Company includes interest and penalties arising from the underpayment of income taxes in the statements of operations in the provision for income taxes.  As of December 31, 2013 and 2012, the Company had no accrued interest or penalties related to uncertain tax positions.
	The tax years that remain subject to examination by major taxing jurisdictions are those for the years ended December 31, 2012, 2011 and 2010.

Going_Concern

Going Concern	12 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Going Concern	'
	NOTE 3 - GOING CONCERN
	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has a negative working capital of $136,602 and has incurred losses of $189,803 since inception. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management’s plan to acquire or merge with other operating companies.

Development_Stage_Company

Development Stage Company	12 Months Ended
	Dec. 31, 2013
Development Stage Enterprises [Abstract]	'
Development Stage Company	'
	NOTE 4 - DEVELOPMENT STAGE COMPANY
	The Company is a development stage company as defined in FASB ASC 915. It is concentrating substantially all of its efforts in raising capital and defining its business operation in order to generate significant revenues.

Accounts_and_Notes_Payable

Accounts and Notes Payable	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Accounts and Notes Payable	'
	NOTE 5 – ACCOUNTS AND NOTES PAYABLE
	Through December 31, 2012, the Company had recorded as accounts payable $80,975 for services as well as cash advances received both from related and unrelated parties. It was the intent of management and counter parties to issue common stock of the Company for these liabilities at some future date therefore they were carried as accounts payable and advances. However, it was subsequently determined that it was not in the best interests of the parties to issue stock for these liabilities, therefore, the parties have agreed that the liabilities will be treated as promissory notes. These accounts payable and advances on the books as of January 1, 2011 were converted to Notes Payable which bear interest at 8% and are due on demand.
	Accrued interest, including related party accrued interest, was $7,039 and $0 at December 31, 2013 and 2012 respectively.
	For the fiscal year ended December 31, 2013, a related party invoiced the Company for consulting, administrative, and professional services and out-of-pocket costs provided to or paid on behalf of the Company totaling $19,700 in 2013 and $20,275 in 2012.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	NOTE 6 - RELATED PARTY TRANSACTIONS
	As of the year ended December 31, 2012, the Company incurred $20,275 of professional fees payable to First Equity Holdings Corp., a shareholder In 2013 these payables were converted into Notes payable – related party, as stated in Note 5. Notes payable – related party at December 31, 2013 and 2012 were $53,025 and $28,250 respectively. Accrued interest on these notes at December 31, 2013 and 2012 was $2,530 and $0 respectively. The notes bear interest at 8% and are due on demand.
	For the year ended December 31, 2013, the Company received cash advances of $4,500 from and incurred $19,700 of professional fees payable to First Equity Holdings Corp.
	As of the year ended December 31, 2013, the Company incurred $19,700 of professional fees payable to First Equity Holdings Corp.

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Stockholders' Equity	'
	NOTE 7 – STOCKHOLDERS’ EQUITY
	In 1997 the Company issued 1,000,000 shares of common stock for cash of $1,000 ($.001 per share). It issued 200,000 shares of stock for services valued at $200. It also issued 3,500,000 shares for cash of $35,000 ($.01 per share).
	In 2000 the Company issued 200,000 shares of stock for services valued at $2,000. It also issued 250,000 shares of stock for services valued at $5,000.
	During 2003, the Company issued 1,000,000 shares of common stock, for services valued at $10,000 (or $.01 per share).
	There was no stock issued during 2013 and 2012.

Fair_Value_Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	NOTE 8 – Fair Value Measurements
	If required by authoritative literature, the Company would account for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. When applicable, we categorize each of our fair value measurements in one of these three levels based on the lowest level input hat significant to the fair value measurement in its entirety. These levels are:
	Level 1 – inputs are based upon unadjusted quoted prices for identical instruments traded in active markets.
	Level 2 - inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3 – Inputs are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.
	The cash, accounts payable, notes payable and accrued interest have fair values that approximate their carrying values due to the short term nature of these instruments

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	NOTE 9 – SUBSEQUENT EVENTS
	The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Organization & Summary of Significant Accounting Policies	'Organization & Summary of Significant Accounting Policies
	Cancer Capital Corp. (the Company), was incorporated April 11, 1997 under the laws of the State of Nevada. The Company was originally formed for the purpose of developing an alternative medical waste treatment system. However, the Company in December 1997 minimized this purpose and since that time its efforts have been directed more to raising capital, development of the Company’s business plan, SEC filings and other limited operations.
Recognition of Revenue	'Recognition of Revenue
	The Company has adopted FASB ASC 605 which provides guidance on the recognition, presentation and disclosure of revenue in financial statements filed with the SEC. FASB ASC 605 outlines the basic criteria that must be met to recognize revenue and provides guidance for disclosure related to revenue recognition policies. In general, the Company recognizes revenue related to monthly services provided when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) the fee is fixed or determinable and (iv) collect ability is reasonably assured.
Loss Per Share	'Loss Per Share
	The computation of earnings per share of common stock is based on the weighted average number of shares outstanding at the date of the financial statements. There are not potentially dilutive common stock equivalents.
		For the Years Ended
		December 31,
		2013			2012
	Net Loss	$	(34,891	)	$	(29,467	)
	Weighted Average Number of Shares Outstanding		6,150,000			6,150,000
	Basic Loss per Common Share	$	(0.01	)	$	(0.00	)
Cash and Cash Equivalents	'Cash and Cash Equivalents
	The Company considers all highly liquid investments with maturities of three months or less to be cash equivalents.
Use of estimates	'Use of estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Concentrations of Risk	'Concentrations of Risk
	As of December 31, 2013, two lenders represent in excess of 95% of the Company’s Accounts Payable and Notes Payable for the fiscal years ended December 31, 2013 and December 31, 2012.
Reclassification	'Reclassification
	Certain amounts in prior-year financial statements have been reclassified for comparative purposes to conform to the presentation in the current year financial statements.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Computation of earnings per share	'
		For the Years Ended
		December 31,
		2013			2012
	Net Loss	$	(34,891	)	$	(29,467	)
	Weighted Average Number of Shares Outstanding		6,150,000			6,150,000
	Basic Loss per Common Share	$	(0.01	)	$	(0.00	)

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Deferred tax assets	'
		For the Years Ended
		December 31,
		2013			2012
	Deferred tax asset:
	Net operating loss carryforward	$	64,533		$	52,670
	Valuation allowance		(64,533	)		(52,670	)
		$	0		$	0
Components of income tax expense	'
		For the Years Ended
		December 31,
		2013			2012
	Current Federal tax	$	0		$	0
	Current State tax		0			0
	Change in NOL benefit		11,863			10,080
	Change in valuation allowance		(11,863	)		(10,080	)
		$	0		$	0
Reconciliation of unrecognized tax benefits	'
		For the Years Ended
		December 31,
		2013			2012
	Beginning Balance	$	0		$	0
	Additions based on tax positions related to current year		0			0
	Additions for tax positions of prior years		0			0
	Reductions for tax positions of prior years		0			0
	Reductions in benefit due to income tax expense		0			0
	Ending Balance	$	0		$	0

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Computation of earnings per share (Details) (USD $)	12 Months Ended		201 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Accounting Policies [Abstract]	'	'	'
Net Loss	($34,891)	($29,467)	($189,803)
Weighted Average Number of Shares Outstanding	6,150,000	6,150,000	'
Basic Loss per Common Share	($0.01)	$0	'

Income_Taxes_Deferred_tax_asse

Income Taxes - Deferred tax assets (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred tax asset:	'	'
Net operating loss carryforward	$64,533	$52,670
Valuation allowance	-64,533	-52,670
[us-gaap:DeferredTaxAssetsGross]	$0	$0

Income_Taxes_Components_of_inc

Income Taxes - Components of income tax expense (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]	'	'
Current Federal tax	$0	$0
Current State tax	0	0
Change in NOL benefit	11,863	10,080
Change in valuation allowance	($11,863)	($10,080)

Income_Taxes_Reconciliation_of

Income Taxes - Reconciliation of unrecognized tax benefits (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]	'	'
Beginning Balance	$0	$0
Additions based on tax positions related to current year	0	0
Additions for tax positions of prior years	0	0
Reduction for tax positions of prior year	0	0
Reductions in benefit due to income tax expense	0	0
Ending Balance	$0	$0

Income_Taxes_Details_Narrative

Income Taxes (Details Narrative) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]	'	'
Net operating loss carry-forwards	$189,803	$154,912

Going_Concern_Details_Narrativ

Going Concern (Details Narrative) (USD $)	201 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Working capital	($136,602)
Total incurred losses	($189,803)

Accounts_and_Notes_Payable_Det

Accounts and Notes Payable (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Debt Disclosure [Abstract]	'	'
Accounts payable for services	$80,975	'
Note payable interest rate	8.00%	'
Accrued interest	7,039	0
Related party debt	$19,700	$20,275

Related_Party_Transactions_Det

Related Party Transactions (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Related Party Transactions [Abstract]	'	'
Related party professional fees	$19,700	$20,275
Notes payabe- related party	53,025	28,250
Accrued interest	2,530	0
Cash advances	$4,500	'

Stockholders_Equity_Details_Na

Stockholders' Equity (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2003	Dec. 31, 2000	Dec. 31, 1997
Equity [Abstract]	'	'	'
Common stock issued for cash	'	'	1,000,000
Cash received for Common stock	'	'	$1,000
Common stock issued for services	1,000,000	200,000	200,000
Value of common stock issued for services	10,000	2,000	200
Common stock issued for cash, second issuance	'	'	3,500,000
Cash received for Common stock, second issuance	'	'	35,000
Common stock issued for services, second issuance	'	'	250,000
Value of common stock issued for services, second issuance	'	'	$5,000